Sign in

Endometrial cancer

Current status: Curable in many cases

A cancer that starts in the lining of the womb, and usually happens after the menopause. The main sign is bleeding from the vagina after the menopause, between periods, or heavier than is normal for you. The most common treatment is surgery to remove the womb, sometimes with radiotherapy, chemotherapy or hormone medicine. Most cases are found early, before the cancer has spread, and these are usually cured.

Read more about endometrial cancer
Where research stands todayUpdated 17 Nov 2026

Trial-stage treatments and research studies you can joinOpen trials for referral

Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsCzechia, all cities, all phases
Your ageShows only trials that take people your age.
Phase
  1. Trial-stage treatmentPhase 3Taking people
    Tests BNT323 or chemotherapy in people with recurring HER2-expressing uterine cancer

    Compares BNT323 with chemotherapy in adults with recurring uterine cancer previously treated with immunotherapy.

    Olomouc, CzechiaAlso Ostrava, PragueAge 18+
  2. Trial-stage treatmentPhase 3Taking people
    Tests sacituzumab tirumotecan with pembrolizumab in endometrial cancer

    Tests sacituzumab tirumotecan plus pembrolizumab in adults with advanced endometrial cancer.

    Nový Jičín, CzechiaAlso Ostrava, PragueAge 18+
  3. Trial-stage treatmentPhase 3Taking people
    Testing radiotherapy with durvalumab after surgery for mismatch-repair deficient endometrial cancer

    Compares radiotherapy with durvalumab against radiotherapy with or without chemotherapy in endometrial cancer.

    Novy Hradec Kralove, CzechiaAlso PragueAge 18+
  4. Trial-stage treatmentPhase 3Taking people
    Puxitatug samrotecan compared with chemotherapy in B7-H4-selected endometrial cancer

    Tests puxitatug samrotecan against chemotherapy in adults with advanced endometrial cancer that progressed.

    Brno, CzechiaAlso Hradec Králové, Nový Jičín, Ostrava, PragueAge 18+
  5. Trial-stage treatmentPhase 3Taking people
    Long-term belzutifan treatment for adults with solid tumors or von Hippel-Lindau disease tumors

    Continues belzutifan for adults with solid tumors or von Hippel-Lindau-related tumors.

    Olomouc, CzechiaAlso PragueAge 18+
  6. Trial-stage treatmentPhase 3Taking people
    Pre-surgery exercise, diet and support for people with gynaecological cancer

    Tests exercise, nutrition and psychological support before surgery in adults with gynaecological cancer.

    Prague, CzechiaAge 18 to 85
  7. Research study
    Follows women with endometrial cancer who receive standard treatment

    Observes how often endometrial cancer returns and how often lymphedema develops after standard care.

    Prague, CzechiaAge 18+
  8. Research studyTaking people
    Using ultrasound and molecular testing to guide lymph node staging in endometrial cancer

    Studies which women with endometrial cancer may not need lymph node staging.

    Hradec Králové, CzechiaAge 18+
  9. Research studyTaking people
    Studies Links Between Gene Changes, Lifestyle and Endometrial Cancer Recurrence

    Observes gene patterns and lifestyle factors in people with endometrial cancer.

    Prague, Czechia

Trials that have ended are not listed here, because nobody can join them. Stopped and finished Endometrial cancer trials (research view)

Take part in research

14 official research programmes take people with this disease. In a biobank or a registry you give a blood or tissue sample, or your health data, for many research teams to use.

See the research programmes

Search the publications

The results open on the publications page in a new tab, so this page stays as it is.

Lists with this disease filtered

Where treatment stands

Most people are found at an early stage, when this cancer is usually cured; once it has spread far, it is rarely cured.

Approved: 7

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 27

Being tested in people. Many treatments at this stage are never approved.

Animal testing stage: 2

Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.

Lab research stage: 4

Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.

Words used here

Placebo: a dummy treatment without the medicine, used for comparison.

Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.

Where this comes from

The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.

A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.

The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.

Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 87 other open phase 2 trials are not listed.

Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for endometrial (womb) cancer. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.

Not medical advice. Talk to your doctor before you change any treatment.

The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.

Support organisations

Patient organisations and helplines in Czechia, for you and your family.

Endometrial cancer organisations in Czechia

  • Liga proti rakovině Praha

    Czech non-profit organisation (ECL member) working for 30 years to reduce cancer mortality in the Czech Republic through prevention, information and patient support.

  • Veronica

    Czech patient organisation bringing together women with endometrial, vulvar, ovarian and cervical cancer and BRCA1/2 mutation carriers.

General support in Czechia

  • Linka první psychické pomoci (116 123)

    Czech nationwide emotional support line on the EU number 116 123, offering free anonymous help to adults in psychological distress.

  • NZIP – Národní zdravotnický informační portál

    Czechia's national health information portal (Ministry of Health) with guaranteed information on diseases, healthy lifestyle and the health system.

International organisations

Patient organisation umbrella bodies

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.No open programme yet
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Approved treatments

7 medicines are approved for endometrial cancer in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.

Checked on 11 Nov 2026 in the official lists of the US (FDA), the EU (EMA), Japan (PMDA, approvals since April 2004), Switzerland (Swissmedic), France (ANSM, medicines approved in France only) and Taiwan (TFDA). For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 4 uncertain matches are left out. Other countries' own approvals were not checked.

“Miracle cure” fact checker

Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

About endometrial cancer

Sources: NHS, NCI PDQ, MedlinePlus, NCI SEER

A cancer that starts in the lining of the womb, and usually happens after the menopause. The main sign is bleeding from the vagina after the menopause, between periods, or heavier than is normal for you. The most common treatment is surgery to remove the womb, sometimes with radiotherapy, chemotherapy or hormone medicine. Most cases are found early, before the cancer has spread, and these are usually cured.

What is it?

The womb (uterus) is where a baby grows during pregnancy. Endometrial cancer starts in the womb's lining, the endometrium. It is the most common kind of womb cancer. The cause is not known, but too much of the hormone oestrogen raises the risk.

It is most common in people who have been through the menopause, but anyone with a womb can get it. Being overweight, some kinds of hormone replacement therapy (HRT), diabetes, never having given birth, a late menopause and the breast cancer medicine tamoxifen raise the risk. It is more likely if close family have had womb, bowel or ovarian cancer, or with an inherited condition called Lynch syndrome. A healthy weight, regular exercise and a balanced diet can lower your chances.

The first signs

The most common sign is bleeding from the vagina that is not normal for you.

  • bleeding or spotting after the menopause;
  • heavy periods that are unusual for you, or bleeding between periods;
  • a change in the discharge from your vagina;
  • pain in the lower back or between the hips (pelvis), or pain during sex;
  • a lump or swelling in your tummy, or peeing or pooing more or less often than usual.

How doctors find out

Your family doctor asks about your symptoms and may examine your tummy and vagina; you can ask for a female doctor or nurse. If cancer is possible, they send you to a specialist. You may have a scan with a small device placed in the vagina, blood tests, a look inside the womb with a thin camera (hysteroscopy), and a biopsy, where cells are taken from the womb lining. The tests can feel uncomfortable but should not hurt.

Results usually take a few weeks. If it is cancer, more scans (CT, MRI or PET) and genetic tests show how far it has spread. A specialist nurse is your main contact during and after treatment.

Current treatment

Surgery to remove the womb is the main treatment, sometimes followed by radiotherapy or chemotherapy to lower the chance of the cancer coming back; hormone therapy, immunotherapy or targeted medicines are used when it has spread or come back.

Will it get worse?

How serious it is depends on how big the cancer is, whether it has spread, and your general health. Irregular bleeding usually makes people see a doctor early, so most cases are found before the cancer has spread; about two in three are still only in the womb when found. Cancer that has spread to other parts of the body is rarely cured.

Medicines: what helps, and what to watch for

Chemotherapy uses medicines to kill cancer cells. It can be given after surgery to lower the chance of the cancer coming back, together with radiotherapy, or to slow the cancer and ease symptoms if it has spread. Hormone therapy blocks the hormones some of these cancers need to grow; it can help when the cancer has spread or you are not well enough for surgery or radiotherapy. Immunotherapy, which helps your immune system find and kill cancer cells, and targeted medicines may be options for advanced cancer or cancer that comes back.

Good to know:

  • Common side effects of chemotherapy are tiredness, feeling sick, a sore mouth, hair loss for a while, and numbness or tingling in the hands or feet;
  • Radiotherapy can cause tiredness, diarrhoea (which should go within a few weeks of treatment ending), vaginal dryness or narrowing, and the menopause;
  • You do not need to wait for your next check-up to raise a side effect that worries you.

Radiotherapy, for some people

Radiotherapy uses high-energy rays to kill cancer cells. It can come from a machine outside the body or from a source placed inside, near the cancer. It may be given after surgery to lower the chance of the cancer coming back, and it can be the main treatment if you cannot have surgery. It can also ease symptoms.

Surgery, for some people

Surgery is the most common treatment, especially for early cancer. The surgeon removes the womb and the neck of the womb (cervix) in an operation called a hysterectomy. Sometimes the ovaries and fallopian tubes, nearby lymph nodes or the upper part of the vagina are removed too. If the cancer has spread or come back, surgery may also remove nearby parts, such as the ovaries and tubes, the bladder or the rectum. Recovery can take a long time. Your team will talk with you about what treatment means for having children.

Is there a cure?

Yes, often. When the cancer is found early and is only in the womb, treatment usually cures it. When it has spread far, it is rarely cured, and treatment aims to control it. Clinical trials are testing new treatments, and joining one may be an option for some people.

See the 437 trials you can join

Median survival

About 3 years with chemotherapy for stage III or IV

Measured in: Stage III or IV, with chemotherapy: the GOG-0209 trial (1,381 women)

The figures behind it

NCI PDQ (health professional): in the GOG-0209 trial (1,381 women), median overall survival was 37 months with carboplatin plus paclitaxel and 41 months with paclitaxel, doxorubicin and cisplatin; in advanced or recurrent cancer after earlier platinum treatment, it was 18.7 months with pembrolizumab plus lenvatinib vs 11.9 months with chemotherapy (KEYNOTE-775). Most cases are found early, and localized disease is usually cured.